These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28353446)

  • 1. Decline and changing profile of hepatitis delta among injection drug users in Spain.
    Aguilera A; Trastoy R; Barreiro P; Costa JJ; de Mendoza C; Peña JM; Soriano V
    Antivir Ther; 2018; 23(1):87-90. PubMed ID: 28353446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program.
    Lin HH; Lee SS; Yu ML; Chang TT; Su CW; Hu BS; Chen YS; Huang CK; Lai CH; Lin JN; Wu JC
    Hepatology; 2015 Jun; 61(6):1870-9. PubMed ID: 25677884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population.
    Chen F; Zhang J; Guo F; Wen B; Luo S; Yuan D; Lin Y; Ou W; Tang P; Dai G; Li F; Liu W; Qu X
    J Gastroenterol Hepatol; 2017 Feb; 32(2):515-520. PubMed ID: 27248508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan.
    Hsieh MH; Wang SC; Hsieh MY; Huang CF; Yeh ML; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Tsai JJ; Chuang WL; Yu ML
    Kaohsiung J Med Sci; 2016 Oct; 32(10):526-530. PubMed ID: 27742037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain.
    Aguilera A; Trastoy R; Rodríguez-Calviño J; Manso T; de Mendoza C; Soriano V
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1060-1062. PubMed ID: 29742524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis delta in HIV-infected individuals in Europe.
    Soriano V; Grint D; d'Arminio Monforte A; Horban A; Leen C; Poveda E; Antunes F; de Wit S; Lundgren J; Rockstroh J; Peters L
    AIDS; 2011 Oct; 25(16):1987-92. PubMed ID: 21857493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important?
    Mendes-Correa MC; Gomes-Gouvêa MS; Alvarado-Mora MV; Da Silva MH; Lázari C; Cavalcanti NC; Alonso FK; Carpinelli CC; Uip DE; Pinho JR
    Int J Infect Dis; 2011 Dec; 15(12):e828-32. PubMed ID: 21999909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort.
    d'Arminio Monforte A; Tavelli A; Salpini R; Piermatteo L; D'Anna S; Carrara S; Malagnino V; Mazzotta V; Brancaccio G; Marchetti GC; Rosselli Del Turco E; Rossotti R; Mussini C; Antinori A; Lo Caputo S; Ceccherini Silberstein F; Gaeta GB; Svicher V; Puoti M;
    Liver Int; 2024 Feb; 44(2):603-613. PubMed ID: 38100128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors.
    Gheorghe L; Csiki IE; Iacob S; Gheorghe C; Trifan A; Grigorescu M; Motoc A; Suceveanu A; Curescu M; Caruntu F; Sporea I; Brisc C; Rogoveanu I; Cerban R; Tugui L; Alexandrescu A
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):413-21. PubMed ID: 26697566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
    Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clade homogeneity and low rate of delta virus despite hyperendemicity of hepatitis B virus in Ethiopia.
    Belyhun Y; Liebert UG; Maier M
    Virol J; 2017 Sep; 14(1):176. PubMed ID: 28899424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status.
    Nicolini LA; Taramasso L; Schiavetti I; Giannini EG; Beltrame A; Feasi M; Cassola G; Grasso A; Bartolacci V; Sticchi L; Picciotto A; Viscoli C;
    Antivir Ther; 2015; 20(2):193-7. PubMed ID: 24963642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of hepatitis B and delta coinfection in Israel.
    Shirazi R; Ram D; Rakovsky A; Bucris E; Gozlan Y; Lustig Y; Shaked-Mishan P; Picard O; Shemer-Avni Y; Ben-Zvi H; Halutz O; Lurie Y; Veizman E; Carlebach M; Braun M; Naftaly MC; Shlomai A; Safadi R; Mendelson E; Sklan EH; Ben-Ari Z; Mor O
    BMC Infect Dis; 2018 Feb; 18(1):97. PubMed ID: 29486716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of hepatitis B and Delta virus strains that spread in the Mediterranean North East Coast of Tunisia.
    Yacoubi L; Brichler S; Mansour W; Le Gal F; Hammami W; Sadraoui A; Ben Mami N; Msaddek A; Cheikh I; Triki H; Gordien E
    J Clin Virol; 2015 Nov; 72():126-32. PubMed ID: 26513762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence and significance of hepatitis D virus infection among treatment-naïve HBsAg-positive patients in Northern Vietnam.
    Sy BT; Ratsch BA; Toan NL; Song le H; Wollboldt C; Bryniok A; Nguyen HM; Luong HV; Velavan TP; Wedemeyer H; Kremsner PG; Bock CT
    PLoS One; 2013; 8(10):e78094. PubMed ID: 24205106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Hepatitis B virus and Hepatitis D virus Coinfection in Western Burkina Faso and molecular characterization of the detected virus strains.
    Sanou AM; Benkirane K; Tinto B; Cissé A; Sagna T; Ilboudo AK; Dording C; Tarnagda Z; Muller CP; Hübschen JM
    Int J Infect Dis; 2018 May; 70():15-19. PubMed ID: 29432880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis D Virus: Introduction and Epidemiology.
    Rizzetto M
    Cold Spring Harb Perspect Med; 2015 Jul; 5(7):a021576. PubMed ID: 26134842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.